284 related articles for article (PubMed ID: 27130930)
41. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
42. Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smears.
Galati L; Equestre M; Bruni R; Accardi L; Torti C; Fiorillo MT; Surace G; Barreca GS; Liberto MC; Focà A; Ciccaglione AR; Di Bonito P
Infect Genet Evol; 2019 Mar; 68():185-193. PubMed ID: 30578936
[TBL] [Abstract][Full Text] [Related]
43. Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages.
Lewis JS; Mirabello L; Liu P; Wang X; Dupont WD; Plummer WD; Pinheiro M; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Mehrad M; O'Boyle C; Lin M; Faden DL; Lang-Kuhs KA
Head Neck Pathol; 2021 Dec; 15(4):1089-1098. PubMed ID: 33797697
[TBL] [Abstract][Full Text] [Related]
44. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.
Schiffman M; Rodriguez AC; Chen Z; Wacholder S; Herrero R; Hildesheim A; Desalle R; Befano B; Yu K; Safaeian M; Sherman ME; Morales J; Guillen D; Alfaro M; Hutchinson M; Solomon D; Castle PE; Burk RD
Cancer Res; 2010 Apr; 70(8):3159-69. PubMed ID: 20354192
[TBL] [Abstract][Full Text] [Related]
45. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
46. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
47. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
48. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
Kang YJ; Lewis H; Smith MA; Simonella L; Neal H; Bromhead C; Canfell K
BMC Infect Dis; 2015 Aug; 15():365. PubMed ID: 26297490
[TBL] [Abstract][Full Text] [Related]
49. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
[TBL] [Abstract][Full Text] [Related]
50. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
[TBL] [Abstract][Full Text] [Related]
51. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.
Sundström K; Eloranta S; Sparén P; Arnheim Dahlström L; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami HO; Ylitalo N
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2469-78. PubMed ID: 20671136
[TBL] [Abstract][Full Text] [Related]
52. Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes.
Pinheiro M; Harari A; Schiffman M; Clifford GM; Chen Z; Yeager M; Cullen M; Boland JF; Raine-Bennett T; Steinberg M; Bass S; Xiao Y; Tenet V; Yu K; Zhu B; Burdett L; Turan S; Lorey T; Castle PE; Wentzensen N; Burk RD; Mirabello L
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696378
[TBL] [Abstract][Full Text] [Related]
53. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women.
Gheit T; Cornet I; Clifford GM; Iftner T; Munk C; Tommasino M; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1315-21. PubMed ID: 21527576
[TBL] [Abstract][Full Text] [Related]
54. Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population.
Hang D; Yin Y; Han J; Jiang J; Ma H; Xie S; Feng X; Zhang K; Hu Z; Shen H; Clifford GM; Dai M; Li N
Virology; 2016 Jan; 488():156-61. PubMed ID: 26650690
[TBL] [Abstract][Full Text] [Related]
55. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
[TBL] [Abstract][Full Text] [Related]
56. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
57. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
58. Molecular epidemiology of human papillomavirus 18 infections in Japanese Women.
Yamaguchi-Naka M; Onuki M; Tenjimbayashi Y; Hirose Y; Tasaka N; Satoh T; Morisada T; Iwata T; Sekizawa A; Matsumoto K; Kukimoto I
Infect Genet Evol; 2020 Sep; 83():104345. PubMed ID: 32360473
[TBL] [Abstract][Full Text] [Related]
59. Human Papillomavirus Type 16
Yao Y; Yan Z; Dai S; Li C; Yang L; Liu S; Zhang X; Shi L; Yao Y
Int J Med Sci; 2019; 16(7):1042-1049. PubMed ID: 31341418
[TBL] [Abstract][Full Text] [Related]
60. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
